Company intelligence / Profile preview

Celling Biosciences

Austin, Texas, United Statescellingbiosciences.com ↗

Ownership: Private
Employees: ~47
Development stage: Commercial

Overview

Celling Biosciences has developed and commercialized systems that enable physicians to collect, process, and deliver autologous cellular therapies at the point of care. The company claims to have pioneered the first system allowing users to regulate/select desired cell types via a patented collection window and integrated ultra-filtration system. No clinical trial results are publicly reported; products are used in clinical practice rather than as investigational drugs/devices.

Therapeutic areas: Other
Modalities: Cell therapyAutologous cell therapy
Industry: Therapeutic Medical Devices

Drug pipeline

3 assets

ART PRP Plus

Commercial

Indications: Orthopedics, Aesthetics

2 more assets in the full pipeline.

Request access →

Beyond the preview

Go deeper on Celling Biosciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Celling Biosciences.

Explore the full profile